Literature DB >> 15534068

Kinetic analysis of 18F-fluorodihydrorotenone as a deposited myocardial flow tracer: comparison to 201Tl.

Robert C Marshall1, Patricia Powers-Risius, Bryan W Reutter, James P O'Neil, Michael La Belle, Ronald H Huesman, Henry F VanBrocklin.   

Abstract

UNLABELLED: The goals of this investigation were to assess the accuracy of (18)F-fluorodihydrorotenone ((18)F-FDHR) as a new deposited myocardial flow tracer and to compare the results to those for (201)Tl.
METHODS: The kinetics of these flow tracers in 22 isolated, erythrocyte- and albumin-perfused rabbit hearts were evaluated over a flow range encountered in patients. The 2 flow tracers plus a vascular reference tracer ((131)I-albumin) were introduced as a bolus through a port just above the aortic cannula. Myocardial extraction, retention, washout, and uptake parameters were computed from the venous outflow curves with the multiple-indicator dilution technique and spectral analysis.
RESULTS: The mean +/- SD initial extraction fractions for (18)F-FDHR (0.85 +/- 0.07) and (201)Tl (0.87 +/- 0.05) were not significantly different, although the initial extraction fraction for (18)F-FDHR declined with flow (P < 0.0001), whereas the initial extraction fraction for (201)Tl did not. The washout of (201)Tl was faster (P < 0.001) and more affected by flow (P < 0.05) than was the washout of (18)F-FDHR. Except for the initial extraction fraction, (18)F-FDHR retention was higher (P < 0.001) and less affected by flow (P < 0.05) than was (201)Tl retention. Reflecting its superior retention, the net uptake of (18)F-FDHR was better correlated with flow than was that of (201)Tl at both 1 and 15 min after tracer introduction (P < 0.0001 for both comparisons).
CONCLUSION: The superior correlation of (18)F-FDHR uptake with flow indicates that it is a better flow tracer than (201)Tl in the isolated rabbit heart. Compared with the other currently available positron-emitting flow tracers ((82)Rb, (13)N-ammonia, and (15)O-water), (18)F-FDHR has the potential of providing excellent image resolution without the need for an on-site cyclotron.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15534068

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  22 in total

1.  Novel SPECT perfusion imaging agents with improved myocardial or liver kinetics: experimental studies and the need for clinical evaluation.

Authors:  Laurent M Riou; Alexis Broisat
Journal:  J Nucl Cardiol       Date:  2010-10       Impact factor: 5.952

2.  Novel and simple carbon-11-labeled ammonium salts as PET agents for myocardial perfusion imaging.

Authors:  Ohad Ilovich; Hana Billauer; Sharon Dotan; Nanette M T Freedman; Moshe Bocher; Eyal Mishani
Journal:  Mol Imaging Biol       Date:  2011-02       Impact factor: 3.488

3.  Biodistribution and stability studies of [18F]fluoroethylrhodamine B, a potential PET myocardial perfusion agent.

Authors:  Vijay Gottumukkala; Tobias K Heinrich; Amanda Baker; Patricia Dunning; Frederic H Fahey; S Ted Treves; Alan B Packard
Journal:  Nucl Med Biol       Date:  2010-02-10       Impact factor: 2.408

4.  Novel F-18-labeled PET myocardial perfusion tracers: bench to bedside.

Authors:  Stephan G Nekolla; Antti Saraste
Journal:  Curr Cardiol Rep       Date:  2011-04       Impact factor: 2.931

5.  Nuclear cardiology needs new "blood".

Authors:  Antti Saraste; Stephan Nekolla; Markus Schwaiger
Journal:  J Nucl Cardiol       Date:  2009-02-14       Impact factor: 5.952

6.  Myocardial uptake of 7'-(Z)-[(123)I]iodorotenone during vasodilator stress in dogs with critical coronary stenoses.

Authors:  Alexis Broisat; Mirta Ruiz; Norman C Goodman; Stephen M Hanrahan; Bryan W Reutter; Kathleen M Brennan; Mustafa Janabi; Saul Schaefer; Denny D Watson; George A Beller; Henry F VanBrocklin; David K Glover
Journal:  Circ Cardiovasc Imaging       Date:  2011-09-14       Impact factor: 7.792

Review 7.  Emerging Tracers for Nuclear Cardiac PET Imaging.

Authors:  Dong-Yeon Kim; Sang-Geon Cho; Hee-Seung Bom
Journal:  Nucl Med Mol Imaging       Date:  2018-05-08

8.  Mitochondrial avid radioprobes. Preparation and evaluation of 7'(Z)-[125I]iodorotenone and 7'(Z)-[125I]iodorotenol.

Authors:  Henry F VanBrocklin; Stephen M Hanrahan; Joel D Enas; Erathodiyil Nandanan; James P O'Neil
Journal:  Nucl Med Biol       Date:  2006-11-28       Impact factor: 2.408

9.  Synthesis of fluorine-18 labeled rhodamine B: A potential PET myocardial perfusion imaging agent.

Authors:  Tobias K Heinrich; Vijay Gottumukkala; Erin Snay; Patricia Dunning; Frederic H Fahey; S Ted Treves; Alan B Packard
Journal:  Appl Radiat Isot       Date:  2009-08-28       Impact factor: 1.513

10.  Effect of the prosthetic group on the pharmacologic properties of 18F-labeled rhodamine B, a potential myocardial perfusion agent for positron emission tomography (PET).

Authors:  Mark D Bartholomä; Vijay Gottumukkala; Shaohui Zhang; Amanda Baker; Patricia Dunning; Frederic H Fahey; S Ted Treves; Alan B Packard
Journal:  J Med Chem       Date:  2012-12-14       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.